ArticleScientific reports2018

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.

Michele Simbolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.